TITLE
a phase 2 trial of DDMVAC and bevacizumab in urothelial cancer

ORGANISM
Homo sapiens

SUMMARY
A prognostic gene expression signature in chemotherapy-na√Øve bladder cancer is predictive of clinical outcomes from neoadjuvant chemotherapy

DESIGN
61 FFPE bladder tumors were used to validate chemo-resistant subtype in bladder cancer

PLATFORM
GPL14951 Illumina HumanHT-12 WG-DASL V4.0 R2 expression beadchip

CITATIONS
Has this study been published? Please login to update or notify GEO .

